MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    The relationship between serum uric acid and depression in patients with essential tremor

    Z. Muruzheva, I. Ivleva, M. Karpenko (Saint-Petersburg, Russian Federation)

    Objective: To identity a correlation between serum indicators oxidative stress (uric acid, malondialdehyde and ceruloplasmin) and clinical symptoms in patients with ET. Background: Essential tremor…
  • MDS Virtual Congress 2020

    Sustained Improvement in Freezing of Gait (FOG) and Treatment Satisfaction at 12 months After Initiation of Carbidopa/Levodopa Enteral Suspension (CLES) in Advanced Parkinson’s Disease (APD) Patients in USA: Interim Results from the PROviDE Study

    R. Pahwa, S. Isaacson, B. Bluett, P. Kandukuri, N. Gupta, Y. Jalundhwala, P. Kukreja, I. Pan, J. Aldred (North Chicago, IL, USA)

    Objective: To evaluate the long-term effectiveness of CLES on FOG and treatment satisfaction in APD patients. Background: FOG, prevalent in about 60% of APD patients,…
  • MDS Virtual Congress 2020

    Linguistic Deficits in Patients with Parkinson’s Disease

    P. Akkunje, Y. Belur, R. Yadav, A. Rajasekaran, P. Yuvaraj, N. Kamble, S. Shivashankar, P. Pal (Bangalore, Karnataka, India)

    Objective: The objective of this study is to assess linguistic processing and production in patients with PD. Background: Parkinson's disease (PD) is a neurodegenerative condition…
  • MDS Virtual Congress 2020

    Implementation of the ParkinsonNet care concept shows better expertise and work satisfaction of health professionals, but improvement of multidisciplinary collaboration takes longer than one year

    I. Sturkenboom, M. Nijkrake, H. Woltjer, J. Fritz, A. Kaysen, M. Tiemessen, J. Kalf (Nijmegen, Netherlands)

    Objective: To evaluate the changes in perceived quality of care for people with Parkinson’s disease (PD) among health professionals (HPs) in Luxembourg at one year…
  • MDS Virtual Congress 2020

    SCA48: Ataxia Plus Chorea in a New Spanish Family

    M.I Gastón, G. Soriano, A. Alonso, S. Pasalodos, J. Salgado, M. Mendioroz (Pamplona, Spain)

    Objective: To describe a new family with Spinocerebellar Ataxia 48 (SCA48) characterized by ataxia and mild chorea as the most prominent initial symptoms as well…
  • MDS Virtual Congress 2020

    A Novel CACNA1A Nonsense Variant [c.6481C>G; (p.Arg2161Gly)] Causing Spino Cerebellar Ataxia Type 6 (SCA6)

    J.P Romero, J. Herreros, S. Santillán, Y. Moreno, A. Andújar (Madrid, Spain)

    Objective: To describe a new missense variant found in a 67 years old woman with progressive ataxia causing a phenotype compatible with SCA 6. Background:…
  • MDS Virtual Congress 2020

    Nivolumab-induced choreoathetosis in a woman with lung cancer – A case report with review of the literature

    J. Johansson Lindgren, M. Esbjörnsson, E. Tüzün, H. Griph, D. Van Westen, G. Sahin (Hässleholm, Sweden)

    Objective: To report an uncommon and severe neurological immune-related adverse event (nirAE) of nivolumab and to provide an overview of the current literature on nirAEs…
  • MDS Virtual Congress 2020

    Long-term safety and efficacy of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects: results of a Phase III study

    F. Pagan, A. Dekundy, M. Althaus, D. Mitsikostas (Washington, DC, USA)

    Objective: To assess the safety and efficacy of incobotulinumtoxinA for benign essential blepharospasm (BEB) in toxin-naïve subjects. Background: IncobotulinumtoxinA is efficacious for BEB. This was…
  • MDS Virtual Congress 2020

    New onset Tongue Tremor with Tacrolimus following Heart Transplantation

    E. Gray, K. Frei (Loma Linda, CA, USA)

    Objective: To report a case of tacrolimus induced tongue tremor. Background: Tongue tremor is uncommon and may present in isolation, as part of a syndrome,…
  • MDS Virtual Congress 2020

    Duration of Effect of IncobotulinumtoxinA for the Treatment of Blepharospasm in Botulinum Toxin-naïve Subjects: Results from a Phase III Study

    F. Pagan, A. Dekundy, M. Althaus, A. Scheschonka, J. Jankovic, D. Mitsikostas (Washington, DC, USA)

    Objective: The efficacy of incobotulinumtoxinA, a botulinum neurotoxin type A free from complexing proteins, was investigated in a randomized, placebo-controlled, prospective, Phase III study in…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley